Volume | 19,839 |
|
|||||
News | - | ||||||
Day High | 14.04 | Low High |
|||||
Day Low | 13.68 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
NeoGenomics Inc | NEO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
13.91 | 13.68 | 14.04 | 13.85 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
262 | 19,839 | $ 13.90 | $ 275,850 | - | 11.03 - 21.22 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
09:54:28 | 48 | $ 14.01 | USD |
NeoGenomics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.75B | 127.61M | - | 591.64M | -87.97M | -0.69 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
NeoGenomics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NEO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 13.69 | 14.47 | 13.34 | 13.79 | 748,728 | 0.30 | 2.19% |
1 Month | 15.71 | 15.79 | 13.34 | 14.27 | 668,438 | -1.72 | -10.95% |
3 Months | 14.65 | 17.49 | 13.34 | 15.13 | 897,186 | -0.66 | -4.51% |
6 Months | 14.47 | 21.22 | 13.33 | 16.32 | 972,829 | -0.48 | -3.32% |
1 Year | 14.34 | 21.22 | 11.03 | 15.84 | 932,687 | -0.35 | -2.44% |
3 Years | 50.93 | 54.74 | 6.00 | 18.17 | 1,174,874 | -36.94 | -72.53% |
5 Years | 20.28 | 61.57 | 6.00 | 23.16 | 1,047,100 | -6.29 | -31.02% |
NeoGenomics Description
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services. |